Defining undifferentiated connective tissue diseases: a challenge for rheumatologists

1 LeRoy EC Maricq HR Kahaleh MB . Undifferentiated connective tissue syndromes. Arthritis Rheum 1980; 23: 341 – 343 .

2 Ganczarczyk L Urowitz MB Gladman DD . Latent lupus. J Rheumatol 1989; 16: 475 – 478 .

3 Greer JM Panush RS . Incomplete lupus erythematosus. Arch Intern Med 1989; 149: 2473 – 2476 .

4 Alarcón GS Williams GV Singer JZ . Early undifferentiated connective tissue disease. I. Early clinical manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well-established connective tissue disease. J Rheumatol 1991; 18: 1332 – 1339 .

5 Clegg DO Williams JH Singer JZ . Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 1991; 18: 1340 – 1343 .

6 Mosca M Tavoni A Neri R Bencivelli W Bombardieri S . Undifferentiated connective tissue diseases: the clinical and serological profiles in 91 patients followed for at least 1 year. Lupus 1998; 7: 95 – 100 .

7 Danieli MG Fraticelli P Franceschini F . Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol 1999; 17: 585 – 591 .

8 Dijkstra S Nieuwenhuys EJ Swaak AJ . The prognosis and outcome of patients referred to an outpatient clinic for rheumatic diseases characterized by the presence of antinuclear antibodies (ANA). Scand J Rheumatol 1999; 28: 33 – 37 .

9 Williams HJ Alarcón GS Joks R . Early undifferentiated tissue disease. VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 1999; 26: 816 – 825 .

10 Mosca M Neri R Bombardieri S . Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999; 17: 615 – 620 .

11 Vila LM Mayor AM Valentin AH Garcia-Soberal M Vila S . Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus. Lupus 2000; 9: 110 – 115 .

12 Swaak AJ van de Brink H Smeenk RJ . Incomplete lupus erythematosus: results of a multicenter study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT). Rheumatology 2001; 40: 89 – 94 .

13 Cavazzana I Franceschini F Belfiore N . Undifferentiated connective tissue disease with antibodies to Ro/SSA: clinical features and follow up of 148 patients. Clin Exp Rheumatol 2001; 19: 403 – 409 .

14 Mosca M Neri R Bencivelli W Tavoni A Bombardieri S . Undifferentiated connective tissue disease: analysis of 83 patients with a minimum follow up of 5 years. J Rheumatol 2002; 29: 2345 – 2349 .

15 Bodolay E Csiki Z Szekanecz Z . Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2003; 21: 313 – 320 .

16 Mosca M Baldini C Bombardieri S . Undifferentiated connective tissue diseases in the 2004. Clin Exp Rheumatol 2004; 22: S14 – S18 .

17 Mosca M Neri R Strigini F . Pregnancy outcome in patients with undifferentiated connective tissue disease: a preliminary study on 25 pregnancies. Lupus 2002; 11: 304 – 307 .

18 Mosca M; Tani C; Bombardieri S; . Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol 2007; 21: 1011–1023.

19 Lom-Orta H Alarcon-Segovia D Diaz-Jouanen E . Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis. Rheumatology 1980; 7: 831 – 837 .

20 Lockshin MD . What is SLE? Editorial. J Rheumatol 1989; 16: 419 – 420 .

21 Asherson RA . New subsets of the antiphospholipid syndrome in 2006: “PRE-APS” (probable APS) and microangiopathic antiphospholipid syndromes (“MAPS”). Autoimmun Rev 2006; 6: 76 – 80 .

22 Rand Mariq H Valter I . A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 2004; 22(Suppl. 33): S5 – S13 .

23 Martinez JB Valero JS Bautista AJ . Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol 2007; 25: 47 – 53 .

24 Vandergheynst F Ocmant A Sordet C . Sibilia Anti-pm/scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients. Clin Exp Rheumatol 2006; 24: 129 – 133 .

25 Tani C Mosca M d'Ascanio A . Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD. Reumatismo 2006; 58: 212 – 218 .

26 Doria A Mosca M Gambari PF Bombardieri S . Defining unclassifiable connective tissue diseases: incomplete, undifferentiated or both? J Rheumatol 2005; 32: 213 – 215 .